Stock screenerAll disclosures →
EDGAR →
KNSA
Conviction 89HealthcareScan · Thu, Jun 25, 2026Three inside down
KNSA$56.95-3.69%
ResistanceSupportVol 14Insider sell3
2
Vol MA14 606.24K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price56.95
Change-3.69%
Gap-0.37%
Rel volume1.47×
Avg volume602.98K
Avg $ vol31.68M
SMA 2051.86
SMA 5051.99
SMA 20044.42
Price vs 50+9.54%
Price vs 200+28.20%
MA stackbullish
50/200 cross—
Supertrendup · 53.30
RSI (14)62
MACD hist0.92
MACD crossbull · 8d
Stoch %K / %D68 / 83
ADX (14)27
+DI / −DI37 / 17
RSI divergence—
MACD divergence—
ATR %+3.86%
ADR %3.90%
52w high59.49
52w low26.33
From 52w high-4.27%
Above 52w low+116.29%
New 52w highNo
SqueezeOff
Bollinger width29.38%
%B0.83
Donchian pos72.22%
Donchian high61.12
Donchian low46.10
AVWAP (52w high)58.81
vs AVWAP high-3.16%
AVWAP (52w low)43.28
vs AVWAP low+31.60%
OBV trendUp
Chaikin MF (20)-0.02
Today vs 20d1.47×
Avg vol (14d)606.24K
Avg vol (20d)602.98K
Avg $ vol (20d)31.68M
Market cap4.5B
RS 3m (vs SPY)+19.32%
RS 6m (vs SPY)+29.17%
RS line new highNo
Trend template8/8
Technical rank85.6
1 week+5.05%
1 month+7.74%
3 months+24.24%
6 months+30.86%
1 year+95.97%
YTD+35.58%
P/E76.23
P/B7.43
P/S6.64
P/FCF32.97
EPS0.7500
Div yield—
ROE9.74%
ROA7.15%
Debt/Eq—
Current3.79
EV/EBITDA54.69
Gross margin—
Net margin8.71%
Rev growth60.09%
EPS growth236.61%
Price target64.00
Target upside12.38%
Analyst ratingBuy
Institutional106.32%
Ent. value4.31B
Revenue214.27M
Net income22.59M
Gross profit—
Free cash flow136.42M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out46.3M
Employees366
ListedThu, May 24, 2018
Free float38.9M
Float %84.2%
Short interest3.04M
Days to cover5.6d
Short volume38.4%
Squeeze score48 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.30 · 3 est
Last EPS vs est$0.27 vs $0.18
Last surprise+50.0% beat
Setup gradeA+
Conviction89 / 100
Pattern quality—
Tech rank85.6 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree inside down
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KNSA
No recent disclosed trades by Congress in KNSA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KNSA · 6 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Patel Sanj K CHAIRMAN & CEO · Class A Ordinary Share · 2026-06-01 | Convert | 900K | — | 2026-06-01 | 2026-06-02 |
Patel Sanj K CHAIRMAN & CEO · Class A Ordinary Share · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
Patel Sanj K CHAIRMAN & CEO · Class B Ordinary Shares · 2026-06-01 | Convert | 900K | $0 | 2026-06-01 | 2026-06-02 |
McCain Tracey L Director · Share Option · 2026-05-29 | Grant | 12.16K | $0 | 2026-05-29 | 2026-06-02 |
Levy Richard S Director · Restricted Share Units · 2026-05-29 | Exercise | 2.8K | $0 | 2026-05-29 | 2026-06-02 |
Baker Bros. Advisors (GP) LLC Director · Class A Ordinary Shares · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
Cole G Bradley Director · Restricted Share Units · 2026-05-29 | Grant | 2.03K | $0 | 2026-05-29 | 2026-06-02 |
Popovits Kimberly J Director · Share Option · 2026-05-29 | Grant | 12.16K | $0 | 2026-05-29 | 2026-06-02 |
BAKER FELIX Director · Non- Qualified Share Option (right to buy) · 2026-05-29 | Grant | 36.47K | $0 | 2026-05-29 | 2026-06-02 |
Popovits Kimberly J Director · Class A Ordinary Share · 2026-05-29 | Exercise | 2.8K | — | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in KNSA
No recent SEC filings on file for KNSA.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.